Literature DB >> 19298755

Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought.

Ryszard M Pluta1, Jacob Hansen-Schwartz, Jens Dreier, Peter Vajkoczy, R Loch Macdonald, Shigeru Nishizawa, Hideotoshi Kasuya, George Wellman, Emanuela Keller, Alois Zauner, Nicholas Dorsch, Joseph Clark, Shigeki Ono, Talat Kiris, Peter Leroux, John H Zhang.   

Abstract

OBJECTIVE: Delayed cerebral vasospasm has long been recognized as an important cause of poor outcome after an otherwise successful treatment of a ruptured intracranial aneurysm, but it remains a pathophysiological enigma despite intensive research for more than half a century.
METHOD: Summarized in this review are highlights of research from North America, Europe and Asia reflecting recent advances in the understanding of delayed ischemic deficit. RESULT: It will focus on current accepted mechanisms and on new frontiers in vasospasm research.
CONCLUSION: A key issue is the recognition of events other than arterial narrowing such as early brain injury and cortical spreading depression and of their contribution to overall mortality and morbidity.

Entities:  

Mesh:

Year:  2009        PMID: 19298755      PMCID: PMC2706525          DOI: 10.1179/174313209X393564

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  72 in total

1.  Intracranial delivery of the nitric oxide donor diethylenetriamine/nitric oxide from a controlled-release polymer: toxicity in cynomolgus monkeys.

Authors:  Travis S Tierney; Gustavo Pradilla; Paul P Wang; Richard E Clatterbuck; Rafael J Tamargo
Journal:  Neurosurgery       Date:  2006-05       Impact factor: 4.654

2.  Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage.

Authors:  R M Pluta; R J Boock; J K Afshar; K Clouse; M Bacic; H Ehrenreich; E H Oldfield
Journal:  J Neurosurg       Date:  1997-08       Impact factor: 5.115

3.  Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms.

Authors:  A ECKER; P A RIEMENSCHNEIDER
Journal:  J Neurosurg       Date:  1951-11       Impact factor: 5.115

4.  Asymptomatic versus symptomatic infarcts from vasospasm in patients with subarachnoid hemorrhage: serial magnetic resonance imaging.

Authors:  M Shimoda; M Takeuchi; J Tominaga; S Oda; A Kumasaka; R Tsugane
Journal:  Neurosurgery       Date:  2001-12       Impact factor: 4.654

5.  Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations.

Authors:  Jens P Dreier; Johannes Woitzik; Martin Fabricius; Robin Bhatia; Sebastian Major; Chistoph Drenckhahn; Thomas-Nicolas Lehmann; Asita Sarrafzadeh; Lisette Willumsen; Jed A Hartings; Oliver W Sakowitz; Jörg H Seemann; Anja Thieme; Martin Lauritzen; Anthony J Strong
Journal:  Brain       Date:  2006-10-25       Impact factor: 13.501

6.  Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.

Authors:  Peter Vajkoczy; Bernhard Meyer; Stefan Weidauer; Andreas Raabe; Claudius Thome; Florian Ringel; Volker Breu; Peter Schmiedek
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

7.  Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage.

Authors:  Paul Klimo; John R W Kestle; Joel D MacDonald; Richard H Schmidt
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

8.  Inhibition of Ca++ sparks by oxyhemoglobin in rabbit cerebral arteries.

Authors:  Ryan P Jewell; Christine M Saundry; Adrian D Bonev; Bruce I Tranmer; George C Wellman
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

9.  Time course of vasospasm in man.

Authors:  B Weir; M Grace; J Hansen; C Rothberg
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

Review 10.  [HMG-CoA reductase inhibitor and risk of stroke].

Authors:  M Endres; U Laufs
Journal:  Nervenarzt       Date:  1998-08       Impact factor: 1.214

View more
  137 in total

1.  SAH-induced MMP activation and K V current suppression is mediated via both ROS-dependent and ROS-independent mechanisms.

Authors:  Masayo Koide; George C Wellman
Journal:  Acta Neurochir Suppl       Date:  2015

2.  Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage.

Authors:  Johannes Woitzik; Jens P Dreier; Nils Hecht; Ingo Fiss; Nora Sandow; Sebastian Major; Maren Winkler; Yuliya A Dahlem; Jerome Manville; Michael Diepers; Elke Muench; Hidetoshi Kasuya; Peter Schmiedek; Peter Vajkoczy
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-07       Impact factor: 6.200

3.  Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study.

Authors:  Benjamin Friedrich; Frank Müller; Sergej Feiler; Karsten Schöller; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-07       Impact factor: 6.200

4.  Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm.

Authors:  Elisa R Zanier; Giovanna Brandi; Giuseppe Peri; Luca Longhi; Tommaso Zoerle; Mauro Tettamanti; Cecilia Garlanda; Anna Sigurtà; Serenella Valaperta; Alberto Mantovani; Maria Grazia De Simoni; Nino Stocchetti
Journal:  Intensive Care Med       Date:  2010-11-12       Impact factor: 17.440

5.  Neutrophil depletion after subarachnoid hemorrhage improves memory via NMDA receptors.

Authors:  Jose Javier Provencio; Valerie Swank; Haiyan Lu; Sylvain Brunet; Selva Baltan; Rohini V Khapre; Himabindu Seerapu; Olga N Kokiko-Cochran; Bruce T Lamb; Richard M Ransohoff
Journal:  Brain Behav Immun       Date:  2016-02-09       Impact factor: 7.217

Review 6.  Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Norihito Shimamura; Hiroki Ohkuma
Journal:  Transl Stroke Res       Date:  2013-11-20       Impact factor: 6.829

Review 7.  Delayed neurological deterioration after subarachnoid haemorrhage.

Authors:  R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

Review 8.  SAHIT Investigators--on the outcome of some subarachnoid hemorrhage clinical trials.

Authors:  R Loch Macdonald; Blessing Jaja; Michael D Cusimano; Nima Etminan; Daniel Hanggi; David Hasan; Don Ilodigwe; Hector Lantigua; Peter Le Roux; Benjamin Lo; Ada Louffat-Olivares; Stephan Mayer; Andrew Molyneux; Audrey Quinn; Tom A Schweizer; Thomas Schenk; Julian Spears; Michael Todd; James Torner; Mervyn D I Vergouwen; George K C Wong; Jeff Singh
Journal:  Transl Stroke Res       Date:  2013-01-07       Impact factor: 6.829

9.  Expression and cell distribution of neuroglobin in the brain tissue after experimental subarachnoid hemorrhage in rats: a pilot study.

Authors:  Wei-De Li; Qing Sun; Xiang-Sheng Zhang; Chun-Xi Wang; Song Li; Wei Li; Chun-Hua Hang
Journal:  Cell Mol Neurobiol       Date:  2013-11-27       Impact factor: 5.046

Review 10.  Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury.

Authors:  Jason K Karimy; Benjamin C Reeves; Kristopher T Kahle
Journal:  Expert Opin Ther Targets       Date:  2020-04-17       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.